Literature DB >> 27888987

Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil).

Talitha Comaru1, Paulo Márcio Pitrez2, Frederico Orlando Friedrich2, Victória D Silveira2, Leonardo A Pinto2.   

Abstract

BACKGROUND: Since June 2011, the Brazilian health system started providing asthma medications (beclomethasone and salbutamol), totally free of charge to patients with asthma. The aim of this study was to evaluate the impact of the provision of free asthma medications on hospital admissions for asthma in Brazil, using a national hospitalization database (DATASUS), comparing the incidence of hospital admissions before and after the free supply of these drugs.
METHODS: Admissions of patients with 1-49 years of age by the Brazilian public health system with the diagnosis of asthma were compared pre (2008-2010) and post (2012-2014) provision of free medicines (beclomethasone and salbutamol). The number of hospital admissions due to asthma and non-respiratory diseases, as well as the amount spent with asthma hospitalization, were obtained from DATASUS, the Brazilian government open-access public health database system.
RESULTS: Admission rates for asthma significantly decreased from 90.09/100.000 (2008-2010) to 59.85/100.000 (2012-2014), when the period pre and post provision of free medicines were compared [OR 0.67 (CI 0.48-0.92)]. Non-respiratory admission rates remained stable, when both periods were also compared.
CONCLUSION: Asthma hospitalization rates significantly decreased in the three-year period after the provision of free medicines to treat asthma. Our findings suggest that the provision of free medications for asthma may have a particular public health impact by its own in developing countries. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Hospital admission; Medication; Steroids

Mesh:

Substances:

Year:  2016        PMID: 27888987     DOI: 10.1016/j.rmed.2016.10.008

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  Tolerogenic Dendritic Cells Reduce Airway Inflammation in a Model of Dust Mite Triggered Allergic Inflammation.

Authors:  Luciana S Aragão-França; Viviane C J Rocha; F H B Costa; José Fernandes Vasconcelos; E S Santos; C F Araújo; Lain C Pontes-de-Carvalho; Luciana Souza de Aragão-França; Viviane Costa Junqueira Rocha; Andre Cronemberger-Andrade; Fábio Henrique Brasil da Costa; Daniel Abensur Athanazio; Daniela Nascimento Silva; Emanuelle Souza Santos; Cássio Santana Meira; Cintia Figueiredo Araujo; Jéssica Vieira Cerqueira; Fabíola Cardillo; Neuza Maria Alcântara-Neves; Milena Botelho Pereira Soares; Lain Carlos Pontes de Carvalho
Journal:  Allergy Asthma Immunol Res       Date:  2018-07       Impact factor: 5.764

2.  Celebrating World Asthma Day in Brazil: is the glass half full or half empty?

Authors:  Marcia Margaret Menezes Pizzichini; Álvaro Augusto Cruz
Journal:  J Bras Pneumol       Date:  2019-05-30       Impact factor: 2.624

3.  Asthma in South African adolescents: a time trend and risk factor analysis over two decades.

Authors:  Cynthia B Baard; Zoe Franckling-Smith; Jacinta Munro; Lesley Workman; Heather J Zar
Journal:  ERJ Open Res       Date:  2021-04-06

4.  Is underuse of Inhaled Corticosteroids for Asthma in India contributing to 42% of global asthma deaths?

Authors:  Sundeep Salvi; Sapna Madas; Deesha Ghorpade; Swapnil Gadhave; Monica Barne
Journal:  Lung India       Date:  2022 Jul-Aug

Review 5.  Asthma management in low and middle income countries: case for change.

Authors:  Kevin Mortimer; Helen K Reddel; Paulo M Pitrez; Eric D Bateman
Journal:  Eur Respir J       Date:  2022-09-15       Impact factor: 33.795

Review 6.  Use of health outcome and health service utilization indicators as an outcome of access to medicines in Brazil: perspectives from a literature review.

Authors:  Luisa Arueira Chaves; Danielle Maria de Souza Serio Dos Santos; Monica Rodrigues Campos; Vera Lucia Luiza
Journal:  Public Health Rev       Date:  2019-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.